Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
Federal Debt: The Baseline and Options for Reform

Federal Debt: The Baseline and Options for Reform

May 13, 2024 | Events

On May 13, experts convened at AEI to discuss the United States’ fiscal trajectory: how we got here, where we’re going, and what we can do to reduce the burden of debt for future generations.

More Concerns with the Massachusetts Millionaire’s Tax

More Concerns with the Massachusetts Millionaire’s Tax

Oct 11, 2022 | Op-Eds

Yesterday, the Wall Street Journal editorial board rightly noted multiple concerns with a November ballot initiative in Massachusetts that would amend the state constitution and establish a millionaire’s tax.

  • Analysis (54)
  • Books (3)
  • Commentary (15)
  • Events (22)
  • Interviews (61)
  • News (56)
  • Op-Eds (103)
  • Press Releases (4)
  • Testimony (21)
  • Biosimilars face barriers
    Alex Brill Featured in AxiosJuly 24, 2026
  • Disparate State Impacts and Enormous Cost of a Gas Tax Holiday
    The Disparate State Impacts and Enormous Cost of a Gas Tax HolidayJune 9, 2026
  • Brill discusses tax code and budget challenges
    ‘Facing the Future’: Alex Brill discusses tax code and budget challengesApril 9, 2026
  • Building an Achievable Fiscal Policy
    2026 Portman Center Symposium: Building an Achievable Fiscal PolicyApril 8, 2026
  • Reduced Charitable Giving
    Senator Booker’s Costly Standard Deduction Proposal Would Reduce Charitable GivingApril 7, 2026
  • FDA Continues to Expedite Biosimilar Development
    FDA Continues to Expedite Biosimilar DevelopmentMarch 18, 2026
  • Government’s Drug Negotiation Program
    Diminishing Returns from the Government’s Drug Negotiation ProgramJanuary 29, 2026
  • ACA Tax Credit Extension Matter
    Would Senate Passage of an ACA Tax Credit Extension Matter?January 14, 2026
  • PBMs Pass Through Rebates
    MGA Brief Examines State and Federal PBM MandatesDecember 1, 2025
  • FDA Moves to Facilitate Biosimilar Development
    FDA Moves to Facilitate Biosimilar DevelopmentOctober 30, 2025
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact